| Sample | Title | Value | Rank |
|---|
| GSM1256958 | SLE-patients; Group 1: CD4 T lymphocytes; active SLE 2 | 2164.34 | 98 |
| GSM1256959 | SLE-patients; Group 1: CD4 T lymphocytes; active SLE 4 | 4333.93 | 99 |
| GSM1256960 | SLE-patients; Group 1: CD4 T lymphocytes; active SLE 7 | 2078.9 | 98 |
| GSM1256961 | SLE-patients; Group 1: CD4 T lymphocytes; active SLE 8 | 3465.75 | 99 |
| GSM1256962 | SLE-patients; Group 1: CD4 T lymphocytes; active SLE 9 | 2347.94 | 99 |
| GSM1256963 | SLE-patients; Group 1: CD4 T lymphocytes; active SLE 12 | 2251.88 | 99 |
| GSM1256972 | Yellow fever vaccinated NDs; Group 4: CD4 T lymphocytes; ND 54 before YFV | 2443.95 | 99 |
| GSM1256976 | Yellow fever vaccinated NDs; Group 5: CD4 T lymphocytes; ND 54 seven days after YFV | 3194.32 | 99 |
| GSM1256973 | Yellow fever vaccinated NDs; Group 4: CD4 T lymphocytes; ND 55 before YFV | 2592.75 | 99 |
| GSM1256977 | Yellow fever vaccinated NDs; Group 5: CD4 T lymphocytes; ND 55 seven days after YFV | 2830.2 | 99 |
| GSM1256974 | Yellow fever vaccinated NDs; Group 4: CD4 T lymphocytes; ND 56 before YFV | 3022.42 | 99 |
| GSM1256978 | Yellow fever vaccinated NDs; Group 5: CD4 T lymphocytes; ND 56 seven days after YFV | 3167.88 | 99 |
| GSM1256975 | Yellow fever vaccinated NDs; Group 4: CD4 T lymphocytes; ND 57 before YFV | 2110.52 | 99 |
| GSM1256979 | Yellow fever vaccinated NDs; Group 5: CD4 T lymphocytes; ND 57 seven days after YFV | 2637.38 | 99 |